Emergent BioSolutions (EBS) Interest & Investment Income (2011 - 2018)
Emergent BioSolutions (EBS) posted Interest & Investment Income of $701000.0 for Q3 2018, up 129.08% on a QoQ basis from $306000.0 in Q2 2018, and up 10.05% year-over-year from $637000.0 in Q3 2017.
Powered by 
Analysis
Emergent BioSolutions (EBS) Interest & Investment Income (2011 - 2018) Analysis & Trends
Emergent BioSolutions has reported Interest & Investment Income for 8 years, with the latest figure at $701000.0 in Q3 2018.
- On a quarterly basis, Interest & Investment Income rose 10.05% year-over-year to $701000.0 in Q3 2018; TTM through Sep 2018 was $1.4 million, a 26.2% decrease from a year earlier, with the FY2017 full-year figure at $1.8 million, up 66.48% from the prior year.
- Interest & Investment Income was $701000.0 for Q3 2018 at Emergent BioSolutions, up from $306000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $2.7 million in Q4 2014, with the low at $31000.0 in Q2 2014.
- Average Interest & Investment Income over 5 years is $393947.4, with a median of $222000.0 recorded in 2018.
- The sharpest annual moves came in 2014 and 2015: Interest & Investment Income soared 15172.22% in 2014, then plunged 95.89% in 2015.
- Over 5 years, Interest & Investment Income stood at $2.7 million in 2014, then slumped by 95.89% to $113000.0 in 2015, then surged by 155.75% to $289000.0 in 2016, then plunged by 44.64% to $160000.0 in 2017, then jumped by 338.12% to $701000.0 in 2018.
- The last three Interest & Investment Income figures came in at $701000.0 (Q3 2018), $306000.0 (Q2 2018), and $222000.0 (Q1 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 89.50 Mn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 27.90 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 35.58 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 701,000.00 |
| Jun 30, 2018 | 306,000.00 |
| Mar 31, 2018 | 222,000.00 |
| Dec 31, 2017 | 160,000.00 |
| Sep 30, 2017 | 637,000.00 |
| Jun 30, 2017 | 583,000.00 |
| Mar 31, 2017 | 373,000.00 |
| Dec 31, 2016 | 289,000.00 |
| Sep 30, 2016 | 358,000.00 |
| Jun 30, 2016 | 219,000.00 |
| Mar 31, 2016 | 186,000.00 |
| Dec 31, 2015 | 113,000.00 |
| Sep 30, 2015 | 104,000.00 |
| Jun 30, 2015 | 273,000.00 |
| Mar 31, 2015 | 82,000.00 |
| Dec 31, 2014 | 2.75 Mn |
| Sep 30, 2014 | 59,000.00 |
| Jun 30, 2014 | 31,000.00 |
| Mar 31, 2014 | 40,000.00 |
| Dec 31, 2013 | 18,000.00 |
API Access
Emergent BioSolutions Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();